Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

194.17
Delayed Data
As of 3:59pm ET
 +0.25 / +0.13%
Today’s Change
119.37
Today|||52-Week Range
199.95
+51.65%
Year-to-Date
4 Hot ETF Charts of Q2 Earnings Season
10:41am / Zacks.com - Paid Partner Content
Illumina (ILMN) Tops Q2 Earnings & Revenues, Raises View
Aug 02 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close193.92
Today’s open194.53
Day’s range192.61 - 194.53
Volume49,182
Average volume (3 months)1,030,346
Market cap$28.4B
Dividend yield--
Data as of 3:59pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-0.97%
Earnings growth (this year)+9.63%
Earnings growth (next 5 years)+14.41%
Revenue growth (last year)+8.05%
P/E ratio38.9
Price/Sales7.90
Price/Book12.90

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+1.29+1.02%
BIVVBioverativ Inc+0.14+0.24%
NBIXNeurocrine Bioscienc...-0.49-0.91%
EXASExact Sciences Corp-0.39-1.00%
Data as of 3:59pm ET, 08/16/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$1.01
Annual revenue (last year)$2.4B
Annual profit (last year)$454.1M
Net profit margin18.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Executive VP-Operations, Products &
Strategy
Ostadan Omead
Corporate headquarters
San Diego, California

Forecasts